â rsrapport Nycomed - Takeda Pharmaceuticals International GmbH

More documents

Recommendations

Info

BOARD OF DIRECTORS1092865131171241 Toni Weitzberg is the Chairman of the Board of Directors. He holds an MBA degree from theUniversity of Wisconsin and has lately, before he joined Nordic Capital in 2000, been Senior VicePresident Europe in Pharmacia & Upjohn, overall responsible for their European sites and MarketCompanies in Europe, Middle East, Africa and former Eastern Europe. He was also a member ofthe Corporate Management Group. He is also currently on the Board of Directors for theKarolinska Institute in Stockholm, Synphora AB and Biora AB.2 Robert Andreen holds a PhD degree in Business economics. Before joining Nordic Capital in1990, he held the position as head of the Merger & Acquisitions Department in SvenskaHandelsbanken. He is also currently on the Board of Directors for Wilson Logistics Group,Mölnlycke Health Care, Elmo-Calf AB, Ahlsell Holding AB and Pulsen AB.3 Håkan Björklund is the CEO of Nycomed Holding A/S. He holds a PhD degree in neuroscienceresearch from the Karolinska Institute in Stockholm. Before joining Nycomed in 1999, he heldthe position of Regional Director in Astra, responsible for sales and marketing in the NordicRegion, UK, Ireland, the Netherlands, Eastern Europe, Greece, and South Africa. He is also currentlya member of the Board of Directors for Perbio Science AB.4 Conny Ditlevsen is an elected employee representative from Nycomed Danmark A/S. Sheholds the position of Manager of Organisation & HRD.5 Jorunn Gaarder is an elected employee representative from Nycomed Pharma AS, theNorwegian subsidiary. She holds the position of secretary for the Nordic Consumer Health division.6 Lars Ingelmark is Senior Vice President and head of Life Science Ventures, Sixth SwedishNational Pension Fund. He is also chairman of the Board of Directors of Svensk Våtmarksfondand member of the Board of Directors of Biora AB, Capio AB, Karo Bio AB, A Carlsson ResearchAB, A+ Science Invest AB, Innoventus Uppsala Life Science AB, Karolinska Investment Fund KB,Medicon Valley Management AB and Mölnlycke Health Care AB.–12–
BOARD OF DIRECTORSMichael A Stevens is Corporate Development Director for Nycomed Amersham plc. He is aFellow of the Chartered Institute of Management Accountants and before Nycomed Amersham,he was Director of International Finance at Gedeon Richter Ltd in Hungary and Group CorporatePlanning Director in Wellcome plc.7 Fredrik Strömholm holds an MSc. Degree in Economics from the Stockholm School ofEconomics. Previously a director of Nordic Capital, he is now an Executive Director of GoldmanSachs International, Stockholm.8 Bo Söderberg has an MSc. Degree in Economics from Stockholm School of Economics.Before joining Nordic Capital in 1997, he held the position as President and CEO ofFöreningsbanken AB. He is currently also on the Board of Directors of Hilding Anders AB andNybron Flooring International S/A.9 Runar Bjørklund is the CFO of Nycomed Holding A/S and is also a deputy member of theBoard of Directors.10 Kristoffer Melinder joined Nordic Capital in 1998 and is also a deputy member of the Boardof directors.11 Theresa Comiskey Olsen is General Counsel and Company Secretary of Nycomed HoldingA/S.12AB.Mark Bulmer is an observer on the Board of Directors from Skandinaviska Enskilda Banken–13–
Page 2: CONTENT ANNUAL REPORT3 This is Nyco
Page 6 and 7: KEY FIGURESDKK million 2000 1999 *)
Page 8 and 9: CHAIRMAN`s REPORTThe Board is very
Page 10 and 11: CHIEF EXECUTIVE OFFICER´s REPORTA
Page 12 and 13: CHIEF EXECUTIVE OFFICER´s REPORTfr
Page 16 and 17: MANAGEMENTThe management group in N
Page 18 and 19: BUSINESS DESCRIPTIONNYCOMED MARKETS
Page 26 and 27: BUSINESS DESCRIPTIONMAIN PRODUCTSC
Page 28 and 29: BUSINESS DESCRIPTIONMAIN PRODUCTSTa
Page 30 and 31: BUSINESS DESCRIPTIONMAIN PRODUCTSNy
Page 32 and 33: BUSINESS DESCRIPTIONPRODUCT ORIGINA
Page 34 and 35: BUSINESS DESCRIPTIONPRODUCT ORIGINA
Page 36 and 37: BUSINESS DESCRIPTIONQUALITY ASSURAN
Page 38 and 39: ACCOUNTSCHIEF FINANCIAL OFFICER`s R
Page 40 and 41: ACCOUNTSCHIEF FINANCIAL OFFICER`s R
Page 42 and 43: ACCOUNTSAUDITOR`s REPORT-40-
Page 44 and 45: ACCOUNTSACCOUNTING PRINCIPLESThe re
Page 46 and 47: ACCOUNTSACCOUNTING PRINCIPLESReceiv
Page 48 and 49: ACCOUNTSCONSOLIDATED BALANCE SHEETN
Page 50 and 51: ACCOUNTSCONSOLIDATED ACCOUNTS NOTES
Page 56 and 57: ACCOUNTSPARENT COMPANY PROFIT AND L
Page 58 and 59: ACCOUNTSPARENT COMPANY BALANCE SHEE
Page 60 and 61: ACCOUNTSPARENT COMPANY ACCOUNTS NOT
Page 62 and 63: ACCOUNTSPARENT COMPANY ACCOUNTS NOT
Page 64 and 65:
ACCOUNTSOVERVIEW OF SUBSIDIARIESPar
Page 66 and 67:
NYCOMED GROUP STRUCTURELEGAL STRUCT
Page 68 and 69:
GermanyNycomed Pharma GmbHFraunhofe
show all

â rsrapport Nycomed - Takeda Pharmaceuticals International GmbH

Create successful ePaper yourself

Delete template?

Save as template?

â rsrapport Nycomed - Takeda Pharmaceuticals International GmbH